EMILY.AI uses more than 40 parameters continuously monitored to customize long-term oxygen therapy in real-time, independent of the ongoing patient’s needs, the type of disease, localization, condition, or situation.
Our latest functional prototype has surpassed other automated closed-loop devices (maximum achieved 81% of the time in secure SpO2) by obtaining an 87% of the time secure SpO2.
Our explainable neural network algorithm applied to the upcoming version is expected to exceed 95% of the time in the secure SpO2 range.
EXECUTIVE TEAM
Daniel Oliva
CEO & Founder
ExDeputy Director at Kosmos BTW others Multinational companies and entrepreneurship projects
Sara Heili, MD
Head Pulmonolgy of Fundación Jiménez Dïaz
Chief Medical Officer
4 times consecutive years Forbes Best 100 Doctors
ADVISORS
Raimon Belenes, MD
Board Member, Partner & Promoter
A Benchmark in C-Level Health Management
Javier Viaña, PhD
Researcher in AI at MIT & Advisor
Best Paper in the US
Worked for NASA and THALES
Dr. Antoni Torres
Ramon Gomis, MD, PhD
Board Member & Research Strategy Advisor
exCEO at IDIBAPS
Board Member in Reig Jofre
Creu Sant Jordi Awarded